ABT vs MDT
Abbott Laboratories (ABT) and Medtronic (MDT) compared side by side. Abbott Laboratories (ABT) is larger, with a market cap of $179.4B versus $122.0B for Medtronic, about 1.5 times the size. On trailing earnings, MDT is cheaper at 23.4x versus 38.6x for ABT.
Head to head
| Metric | ABT | MDT |
|---|---|---|
| Market cap | $179.4B | $122.0B |
| P/E (TTM) | 38.6x | 23.4x |
| Forward P/E | 17.4x | 14.9x |
| Revenue (TTM) | $48.2B | $37.5B |
| Revenue growth | 14.5% | 13.7% |
| Gross margin | 57.1% | 65.3% |
| Operating margin | 11.3% | 19.3% |
| Free cash flow | $7.4B | $6.1B |
| Dividend yield | 2.43% | 3.02% |
| 1-year return | -15.9% | +4.6% |
| 5-year return (annual) | -2.0% | -1.9% |
| Max drawdown | -46% | -73% |
| FI Handbook grade | C+ | B- |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
ABT vs MDT FAQ
Which is bigger, ABT or MDT?
Abbott Laboratories (ABT) is larger, with a market cap of $179.4B versus $122.0B for Medtronic, about 1.5 times the size.
Is ABT or MDT cheaper?
On trailing earnings, MDT is cheaper at 23.4x versus 38.6x for ABT. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, ABT or MDT?
MDT returned +4.6% over the past year including dividends, versus -15.9% for ABT, through October 23, 2026.
Which pays a higher dividend, ABT or MDT?
MDT yields 3.02% versus 2.43% for ABT.
Full pages: Abbott Laboratories · Medtronic